Author

Junko Yamaoka

Observed names: J YAMAOKA, J Yamaoka, J. Yamaoka

Institution: Kyoto Saiseikai Hospital

Observed institutions: Kyoto University, Kyoto Prefectural University of Medicine, Kyoto Saiseikai Hospital

OpenAlex ID: A5074414830

Suppressive effect of zinc ion on iNOS expression induced by interferon-γ or tumor necrosis factor-α in murine keratinocytes

2000 · J Yamaoka · Journal of Dermatological Science · 57

Successful Treatment of a Previously Healthy Woman with Pseudomonas aeruginosa Community-acquired Pneumonia with Plasmapheresis

2012 · Masashi Okamoto, Junko Yamaoka, et al. · Internal Medicine · 16

Greater age and hepatocellular aging are independent risk factors for hepatocellular carcinoma arising from non‐B non‐C non‐alcoholic chronic liver disease

2011 · Tomoki Nakajima, Toshiaki Nakashima, et al. · Pathology International · 11

First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C

2006 · A MAKIYAMA, Y ITOH, et al. · Hepatology Research · 9

Age is a Negative, and Visceral Fat Accumulation is a Positive, Contributor to Hepatic Steatosis, Regardless of the Fibrosis Progression in Non-alcoholic Fatty Liver Disease

2012 · Tomoki Nakajima, Tomoki Nakashima, et al. · Journal of Gastroenterology and Hepatology Research · 8

Prediction of Breakthrough Hepatitis due to Lamivudine-Resistant Hepatitis B Virus by a Sensitive Semiquantitative Assay Using Peptide Nucleic Acids

2006 · Kojiro Mori, Masahito Minami, et al. · Intervirology · 5

Eosinophilic Cholangitis with Poor Prognosis after Corticosteroid- and Ursodeoxycholic Acid-Related Remission of Peripheral and Peribiliary Eosinophilia

2021 · Takahito Shimomura, Tomoki Nakajima, et al. · Case Reports in Gastroenterology · 2

Rapid regrowth of a large hepatic cyst following spontaneous rupture

2014 · Tomoki Nakajima, Manabu Okajima, et al. · International Journal of Case Reports and Images

994 Hepatocyte Nuclear Size, a Reliable Marker of Hepatocellular Aging, Is Useful to Identify the High Risk Group of Hepatocarcinogenesis in Non-b Non-c Non-alcoholic Liver Disease

2011 · T. Nakajima, J. Yamaoka, et al. · Journal of Hepatology

1185 First phase HCV kinetics in interferon and ribavirin combination therapy is an useful predictor of treatment response in chronic hepatitis C patients

2003 · A MAKIYAMA, Y ITOH, et al. · Hepatology

Works count: 10

Citation count: 108

H-index: 5

I10-index: 3